These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28562582)

  • 21. Immunoglobulin expression in the endoplasmic reticulum shapes the metabolic fitness of B lymphocytes.
    Jumaa H; Caganova M; McAllister EJ; Hoenig L; He X; Saltukoglu D; Brenker K; Köhler M; Leben R; Hauser AE; Niesner R; Rajewsky K; Reth M; Jellusova J
    Life Sci Alliance; 2020 Jun; 3(6):. PubMed ID: 32341085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.
    Akhter A; Street L; Ghosh S; Burns BF; Elyamany G; Shabani-Rad MT; Stewart DA; Mansoor A
    Hematol Oncol; 2017 Mar; 35(1):79-86. PubMed ID: 26354285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival.
    Corso J; Pan KT; Walter R; Doebele C; Mohr S; Bohnenberger H; Ströbel P; Lenz C; Slabicki M; Hüllein J; Comoglio F; Rieger MA; Zenz T; Wienands J; Engelke M; Serve H; Urlaub H; Oellerich T
    Proc Natl Acad Sci U S A; 2016 May; 113(20):5688-93. PubMed ID: 27155012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor.
    Kondo E; Harashima A; Takabatake T; Takahashi H; Matsuo Y; Yoshino T; Orita K; Akagi T
    Eur J Immunol; 2003 Jan; 33(1):1-11. PubMed ID: 12594826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas.
    Choi J; Ceribelli M; Phelan JD; Häupl B; Huang DW; Wright GW; Hsiao T; Morris V; Ciccarese F; Wang B; Corcoran S; Scheich S; Yu X; Xu W; Yang Y; Zhao H; Zhou J; Zhang G; Muppidi J; Inghirami GG; Oellerich T; Wilson WH; Thomas CJ; Staudt LM
    Cancer Cell; 2024 May; 42(5):833-849.e12. PubMed ID: 38701792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis.
    Wen R; Chen Y; Bai L; Fu G; Schuman J; Dai X; Zeng H; Yang C; Stephan RP; Cleveland JL; Wang D
    Mol Cell Biol; 2006 Dec; 26(24):9364-76. PubMed ID: 17030619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
    Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
    Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genes regulating the B cell receptor pathway are recurrently mutated in primary central nervous system lymphoma.
    Montesinos-Rongen M; Schäfer E; Siebert R; Deckert M
    Acta Neuropathol; 2012 Dec; 124(6):905-6. PubMed ID: 23138649
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-tumor activity of a B-cell receptor-targeted peptide in a novel disseminated lymphoma xenograft model.
    Wehr C; Müller F; Schüler J; Tomann T; Nitschke C; Seismann H; Spillner E; Klingner K; Schneider-Merck T; Binder M; Fiebig HH; Mertelsmann R; Trepel M
    Int J Cancer; 2012 Jul; 131(2):E10-20. PubMed ID: 21953178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
    Hagiyama H; Adachi T; Yoshida T; Nomura T; Miyasaka N; Honjo T; Tsubata T
    Oncogene; 1999 Jul; 18(28):4091-8. PubMed ID: 10435590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors.
    Derenzini E; Mondello P; Erazo T; Portelinha A; Liu Y; Scallion M; Asgari Z; Philip J; Hilden P; Valli D; Rossi A; Djaballah H; Ouerfelli O; de Stanchina E; Seshan VE; Hendrickson RC; Younes A
    Cell Rep; 2018 Aug; 24(8):2155-2166. PubMed ID: 30134175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCL-W has a fundamental role in B cell survival and lymphomagenesis.
    Adams CM; Kim AS; Mitra R; Choi JK; Gong JZ; Eischen CM
    J Clin Invest; 2017 Feb; 127(2):635-650. PubMed ID: 28094768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes.
    Craxton A; Shu G; Graves JD; Saklatvala J; Krebs EG; Clark EA
    J Immunol; 1998 Oct; 161(7):3225-36. PubMed ID: 9759836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective calcium signaling and disrupted CD20-B-cell receptor dissociation in patients with common variable immunodeficiency disorders.
    van de Ven AA; Compeer EB; Bloem AC; van de Corput L; van Gijn M; van Montfrans JM; Boes M
    J Allergy Clin Immunol; 2012 Mar; 129(3):755-761.e7. PubMed ID: 22130422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.
    De Falco G; Ambrosio MR; Fuligni F; Onnis A; Bellan C; Rocca BJ; Navari M; Etebari M; Mundo L; Gazaneo S; Facchetti F; Pileri SA; Leoncini L; Piccaluga PP
    BMC Cancer; 2015 Oct; 15():668. PubMed ID: 26453442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.
    Amato T; Abate F; Piccaluga P; Iacono M; Fallerini C; Renieri A; De Falco G; Ambrosio MR; Mourmouras V; Ogwang M; Calbi V; Rabadan R; Hummel M; Pileri S; Leoncini L; Bellan C
    Am J Clin Pathol; 2016 Jan; 145(1):116-27. PubMed ID: 26712879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications.
    Sewastianik T; Prochorec-Sobieszek M; Chapuy B; Juszczyński P
    Biochim Biophys Acta; 2014 Dec; 1846(2):457-67. PubMed ID: 25199984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.